SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.260+0.3%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Finley who wrote (457)3/9/1999 5:25:00 PM
From: Gerald Walls  Read Replies (1) of 645
 
Does anyone follow this stock any more?

Briefing.Com sez:

Aviron (AVIR) 22 3/16 +13/16: SG Cowen upgrades developer and marketer of vaccines from "buy" to "strong buy" as lead product FluMist has $500-plus mln sales potential; company focusing on live, attenuated virus vaccines; sentiment has been negative due to concerns about AVIR bringing manufacturing in line; expects company to do so; has a new price target of $43.....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext